| Insider Name | Buy/Sell | Amount | Shares Change | |||
|---|---|---|---|---|---|---|
| May 12, 2025 | May 13, 2025 | Ryder Sean GC | Sell | $2.92 | $13,067 | -8.59% |
| May 12, 2025 | May 13, 2025 | Zindrick Thomas Pres CEO | Sell | $2.92 | $31,431 | -5.32% |
| May 12, 2025 | May 13, 2025 | Yu Yong VP Clinical Trial Operations | Sell | $2.92 | $16,291 | -10.48% |
| May 12, 2025 | May 13, 2025 | Cappello Joseph VP Pharmaceutical Development | Sell | $2.92 | $13,832 | -8.31% |
| May 12, 2025 | May 13, 2025 | Smalling Ralph Head of Regulatory | Sell | $2.92 | $3,676 | -3.50% |
| Dec 30, 2024 | Dec 31, 2024 | Tyree James L Dir | Sell | $2.46 | $8,512 | -7.03% |
| Dec 16, 2024 | Dec 18, 2024 | Zindrick Thomas Pres CEO | Sell | $2.34 | $33,497 | -27.70% |
| Dec 16, 2024 | Dec 18, 2024 | Zak Lourie S. CFO | Sell | $2.34 | $4,921 | -4.90% |
| Dec 16, 2024 | Dec 18, 2024 | Smalling Ralph Head of Regulatory | Sell | $2.34 | $5,873 | -13.33% |
| Dec 16, 2024 | Dec 18, 2024 | Cappello Joseph VP Pharmaceutical Development | Sell | $2.34 | $14,742 | -30.07% |
| Sep 12, 2024 | Sep 13, 2024 | Szalay Aladar 10% | Sell | $2.65 | $171,678 | -1.86% |
| Sep 11, 2024 | Sep 13, 2024 | Tyree James L Dir | Sell | $2.6 | $4,499 | -3.51% |
| Sep 09, 2024 | Sep 11, 2024 | Szalay Aladar 10% | Sell | $2.62 | $196,609 | -2.11% |
| Sep 03, 2024 | Sep 06, 2024 | Szalay Aladar 10% | Sell | $2.09 | $89,614 | -1.19% |
| Aug 28, 2024 | Aug 30, 2024 | Szalay Aladar 10% | Sell | $2.09 | $554,411 | -6.88% |
| Aug 23, 2024 | Aug 27, 2024 | Szalay Aladar 10% | Sell | $2.19 | $200,278 | -2.32% |
| Jun 24, 2024 | Jul 08, 2024 | Yu Yong VP Clinical Trial Operations | Sell | $2.12 | $14,520 | -38.66% |
| Jun 24, 2024 | Jul 08, 2024 | Ryder Sean GC | Sell | $2.12 | $11,652 | -22.09% |
| Jun 24, 2024 | Jul 08, 2024 | Jewett Caroline Head of Quality | Sell | $2.12 | $10,517 | -23.47% |
| May 29, 2024 | Jun 08, 2024 | Tyree James L Dir | Buy | ~ | $0 | +39.16% |
| May 29, 2024 | Jun 08, 2024 | Smither John W Dir | Buy | ~ | $0 | +32.18% |
| May 29, 2024 | Jun 08, 2024 | Thomas John Dir | Buy | ~ | $0 | +0.53% |
| May 29, 2024 | Jun 08, 2024 | Mirabelli Mary Dir | Buy | ~ | $0 | +39.10% |
| May 29, 2024 | Jun 08, 2024 | Yu Yong VP Clinical Trial Operations | Buy | ~ | $0 | +50.00% |
| May 29, 2024 | Jun 08, 2024 | Zindrick Thomas Pres CEO | Buy | ~ | $0 | +48.23% |
| May 29, 2024 | Jun 08, 2024 | Smalling Ralph Head of Regulatory | Buy | ~ | $0 | +8.58% |
| May 29, 2024 | Jun 08, 2024 | Ryder Sean GC | Buy | ~ | $0 | +48.61% |
| May 29, 2024 | Jun 08, 2024 | Zak Lourie S. CFO | Buy | ~ | $0 | +50.00% |
| May 13, 2024 | May 15, 2024 | Szalay Aladar 10% | Sell | $3.63 | $130,377 | -0.90% |
| May 07, 2024 | May 09, 2024 | Szalay Aladar 10% | Sell | $3.78 | $75,300 | -0.50% |